UNSPSC 51386011: Mabuprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C15H23NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 02B8S6J90B, chemically known as benzeneacetamide, n-(2-hydroxyethyl)-alpha-methyl-4-(2-methylpropyl)- but generally known as mabuprofen, which bears US NIH Compound Identifier 71261. European Medicines Agency schedules Mabuprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08630MIG.

UNSPSC 51386011 Mabuprofen is a Commodity code, but the recent state and local opportunities posted under this code show minimal alignment with ibuprofen or other nonsteroidal anti-inflammatory drugs. Instead, the three most recent solicitations posted under this code cover naloxone procurement, direct-to-manufacturer prescription programs, and multi-source generic pharmaceuticals and OTC products—none of which involve mabuprofen or branded ibuprofen formulations. The code appears to be applied inconsistently across state and local buying offices, and no concrete recent opportunities for mabuprofen itself are evident in the current market activity.

The issuing bodies span state health agencies, county health departments, and cooperative purchasing alliances: Seminole County, Florida (an IFB for naloxone and drug deactivation systems posted June 30, 2026, due July 26, 2023); the Texas Health and Human Services Commission (an RFI for direct-to-manufacturer prescription programs posted April 3, 2026); and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) administered by the Minnesota Department of Administration (an RFP for generic multi-source pharmaceuticals and OTC products posted January 20, 2026, due March 26, 2026). Geographic activity centers on Florida, Texas, and Minnesota, with MMCAP participation extending to Oregon and other states in the cooperative. Given the mismatch between the code's nominal scope and the recent opportunities posted under it, the code shows little relevant activity for mabuprofen-specific procurement right now.